Showing results (51-60 of 101) with videos related to
Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|March 18, 2015
Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR-TKI and mTOR inhibitorInkeun Park, Jae-Lyun Lee, Jin-Hee Ahn, et al.Japanese Journal of Clinical Oncology|December 5, 2008
Dose escalation of imatinib after failure of standard dose in Korean patients with metastatic or unresectable gastrointestinal stromal tumorInkeun Park, Min-Hee Ryu, Sun Jin Sym, et al.Cancer Research and Treatment|December 27, 2024
Pemetrexed Maintenance versus Observation in Patients with Advanced Urothelial Carcinoma Who Completed First-line Platinum-based Chemotherapy without Disease Progression (PREMIER, KCSG GU16-05)Inkeun Park, Shinkyo Yoon, Ilhwan Kim, et al.American Journal of Clinical Oncology|March 12, 2021
Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based ChemotherapyJoo-Hwan Park, Ja Hyun Yeo, Young Saing Kim, et al.Cancer|June 19, 2009
Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapyInkeun Park, Jae-Lyun Lee, Min-Hee Ryu, et al.Cancer Chemotherapy and Pharmacology|December 22, 2015
Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinomaDong-Hoe Koo, Inkeun Park, Jin-Hee Ahn, et al.Cancer Chemotherapy and Pharmacology|September 6, 2014
Non-surgical treatment versus radical esophagectomy for clinical T1N0M0 esophageal carcinoma: a single-center experienceInkeun Park, Yong-Hee Kim, Dok Hyun Yoon, et al.JCO Clinical Cancer Informatics|January 18, 2019
Assessing Concordance With Watson for Oncology, a Cognitive Computing Decision Support System for Colon Cancer Treatment in KoreaWon-Suk Lee, Sung Min Ahn, Jun-Won Chung, et al.European Journal of Cancer (Oxford, England : 1990)|August 19, 2022
Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failureShinkyo Yoon, Sang Joon Shin, Ho Cheol Kim, et al.Chemotherapy|April 4, 2013
Comparative efficacy of sunitinib versus sorafenib as first-line treatment for patients with metastatic renal cell carcinomaSeong Joon Park, Jae-Lyun Lee, Inkeun Park, et al.Pageof 11